BEAM
Beam Therapeutics Inc.
Company Overview
| Mkt Cap | $2.66B | Price | $25.01 |
| Volume | 3.59M | Change | +5.08% |
| P/E Ratio | -7.1 | Open | $23.80 |
| Revenue | $63.5M | Prev Close | $23.80 |
| Net Income | $-376.7M | 52W Range | $13.53 - $35.25 |
| Div Yield | N/A | Target | $46.14 |
| Overall | 48 | Value | 60 |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyBeam Therapeutics Inc. (BEAM) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $25.01 with a market capitalization of $2.66 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BEAM with a volume of 3.59 million shares. The stock opened down 0.00% from yesterday's close of $23.80. Current analyst estimates project earnings of $-4.23 per share for this year, with next year targeting $-4.21.
BEAM demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for BEAM include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 84.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 11:52 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BEAM | $25.01 | +5.1% | 3.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |